Health
Amazon, Rite Aid Can’t Get Enough Supply of Weight-Loss Drug Zepbound
This article is for subscribers only.
Eli Lilly & Co. said that some patients may have trouble getting its new weight loss drug Zepbound as complaints of backorders and delays mount across the US.
“Due to the unprecedented demand for these medicines, some patients may experience difficulty when trying to fill their prescription at their pharmacy,” a Lilly spokesperson said.